Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Critical Care"
DOI: 10.1016/j.jcrc.2020.08.002
Abstract: Abstract Introduction The novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has emerged early December 2019 and was recently confirmed by the World Health Organization (WHO) to be a public health emergency of international concern.…
read more here.
Keywords:
arterial thromboembolism;
thromboembolism patients;
severe arterial;
thromboembolism ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Seminars in Vascular Surgery"
DOI: 10.1053/j.semvascsurg.2021.06.002
Abstract: Abstract Venous thromboembolic complications have emerged as serious sequelae in COVID-19 infections. This article summarizes the most current information regarding pathophysiology, risk factors and hematologic markers, incidence and timing of events, atypical venous thromboembolic complications,…
read more here.
Keywords:
risk;
thromboembolism patients;
risk factors;
venous thromboembolism ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Thrombosis and haemostasis"
DOI: 10.1055/s-0039-3400303
Abstract: Risk factors for venous thromboembolism in patients with solid tumors are well studied; however, studies in patients with acute leukemia are lacking. We conducted a retrospective cohort study of adult patients diagnosed with acute myeloid…
read more here.
Keywords:
risk;
thromboembolism patients;
thromboembolism;
venous thromboembolism ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.15758
Abstract: Venous thromboembolism (VTE) is a concern for patients with newly diagnosed multiple myeloma.
read more here.
Keywords:
prediction venous;
patients multiple;
venous thromboembolism;
thromboembolism patients ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-3217
Abstract: Background: Immune checkpoint inhibitors with or without chemotherapy form the backbone of treatment for patients with advanced NSCLC without an actionable driver mutation. Emerging literature shows that ICIs increase the risk of venous thromboembolism (VTE),…
read more here.
Keywords:
risk thromboembolism;
thromboembolism patients;
cancer;
chemoio ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.5042
Abstract: 5042Background: Most pts with bladder cancer will be treated with immunotherapy. There is concern for increased TE risk with CPIs in this already high risk population. We present the first analysis...
read more here.
Keywords:
pts bladder;
bladder cancer;
thromboembolism patients;
cancer treated ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0274969
Abstract: This study evaluated effectiveness and safety of apixaban versus warfarin among venous thromboembolism patients at high-risk of bleeding (defined as having at least one of the following bleeding risk factors: ≥75 years; used antiplatelet, NSAIDs,…
read more here.
Keywords:
patients high;
venous thromboembolism;
risk;
thromboembolism patients ... See more keywords